Clinical trials, adaptability and the COVID-19 pandemic

Despite the impact of the COVD-19 pandemic and public health crisis on health care delivery, the GOG-Foundation has continued to prioritize the delivery of novel and state-of-the-science treatment options to patients via clinical trials.

Detalles Bibliográficos
Autores principales: Eskander, Ramez N., Pothuri, Bhavana, Randall, Leslie, O'Malley, David, Slomovitz, Brian, Moore, Kathleen, Coleman, Robert, Herzog, Thomas, Monk, Bradley J., Copeland, Larry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723439/
https://www.ncbi.nlm.nih.gov/pubmed/33319009
http://dx.doi.org/10.1016/j.gore.2020.100680

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723439/
https://www.ncbi.nlm.nih.gov/pubmed/33319009
http://dx.doi.org/10.1016/j.gore.2020.100680

Ejemplares similares